article thumbnail

Lomecel-B CLEARMIND Phase 2a Trial Results to Be Presented at AAIC

Pharmacy Times

Safety and efficacy findings on Lomecel-B will be presented at the upcoming 2024 Alzheimer’s Association International Conference, which will be held July 28 to August 1.

139
139
article thumbnail

What States are Doing to Regulate Pharmacy Benefit Managers

Drug Topics

In a poster presented at the 2024 American Pharmacists Association Annual Meeting and Exposition, researchers assessed state-level regulations for PBMs.

247
247
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Obesity is Common in Individuals with Celiac Disease

Drug Topics

In an abstract presented at Digestive Disease Week 2024, researchers analyzed the prevalence of obesity in patients with and without celiac disease.

232
232
article thumbnail

USP Compliance Presents Unique Challenges for Outpatient Oncology

Pharmacy Times

Compliance is achievable for outpatient oncology practices with careful planning and execution.

123
123
article thumbnail

Chronic Hand Eczema Studies Show Condition is Common, Burdensome

Drug Topics

LEO Pharma presented data from 2 of the largest multinational real-world studies on the prevalence, severity and treatment of chronic hand eczema at the European Society of Contact Dermatitis congress.

234
234
article thumbnail

ASHP Midyear: High Costs of Gene Therapies Present Major Challenges to Implementation

Pharmacy Times

According to the report, 75% of survey participants expect pharmacists to oversee these therapies and 58% expect Medicare will require pharmacist involvement.

139
139
article thumbnail

Clinical Presentation in Patients With Lymphoma Widely Vary, Making Treatment Difficult

Pharmacy Times

A variety of signs and symptoms of lymphoma were reported, including fever, stomach discomfort, and weight loss.

132
132